Possibilities of cardiac resynchronization therapy and ablation of the atrioventricular conjunction in patients with heart failure and atrial fibrillation
FDA expedited access pathway enables staged approval opportunity for baroreflex activation therapy for heart failure with reduced ejection fraction: the BeAT-HF trial